April Newsletter: Integrated Technologies to Accelerate Process Intensification for Viral Vaccine Manufacturing

Integrated Technologies to Accelerate Process Intensification for Viral Vaccine Manufacturing

With the increasing world-wide demand for viral-based vaccines (VBVs) which includes attenuated and inactivated viral vaccines, as well as viral vector vaccines to protect against the coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), faster development times are required to progress VBVs more rapidly into clinical development and then to market. Read the full story

Product Spotlight

Suite Beta Bag 

The Suite Single-Use Beta Bag is a safe, efficient, and cost-effective solution for aseptic production. This single-use system provides contamination-free transfer of sterile components into isolation or removal of toxic components out of isolators.

Learn more

Case Study

Annex 1 and Cleaning Costs

Upcoming changes due to Annex 1 require modification of cleaning validation and a separation of cleaning and disinfecting procedures. We performed an analysis of Suite® products and their total cost of ownership.

Read more